Potassium Ion

Potassium Ion

SCHEMBL3131828

N#CCOP(=O)([O-])[O-].[K+].[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL3897706 0.97
SCHEMBL937334 0.97
SCHEMBL926219 0.95
Ammonia Solution, Strong SCHEMBL976623 0.92
Potassium Ion SCHEMBL5803916 0.89 SLC34A1 (0.32)
SCHEMBL9098975 0.80
Potassium Ion SCHEMBL5689772 0.80
Tetrabuthylammonium SCHEMBL2824667 0.77 SLC22A1 (0.41)
SCHEMBL6645670 0.75 TSHR (0.38)
Potassium Ion SCHEMBL5807703 0.74 TPI1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105603016-B A method of S-Leucine is prepared using leucine dehydrogenase coupling glucose dehydrogenase 江南大学 2019-03-01 CN disclosed
CN-105603016-A Method for preparing L-tert-leucine by coupling leucine dehydrogenase with glucose dehydrogenase UNIV JIANGNAN 2016-05-25 CN disclosed
WO-2010013925-A2 PHARMACOLOGICAL COMPOSITION FOR PREVENTION AND TREATMENT OF RESPIRATORY DISEASE CONTAINING PYRAZOLOPYRIMIDINONE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF DONG-A PHARMACEUTICAL. CO., LTD. (KR) 2010-02-04 WO disclosed
US-7378555-B2 Method of synthesizing camptothecin-relating compounds KABUSHIKI KAISHA YAKULT HONSHA (JP) 2008-05-27 US disclosed
US-20070010674-A1 Method of synthesizing camptothecin-relating compounds KABUSHIKI KAISHA YAKULT HONSHA (JP) 2007-01-11 US disclosed
US-7126000-B2 Method of synthesizing camptothecin-relating compounds KABUSHIKI KAISHA YAKULT HONSHA (JP) 2006-10-24 US disclosed
US-20040106830-A1 Method of synthesizing camptothecin-relating compounds KABUSHIKI KAISHA YAKULT HONSHA (JP) 2004-06-03 US disclosed
EP-1378505-A1 METHOD OF SYNTHESIZING CAMPTOTHECIN-RELATING COMPOUNDS Kabushiki Kaisha Yakult Honsha (JP) 2004-01-07 EP disclosed
EP-1029863-B1 CAMPTOTHECIN DERIVATIVES YAKULT HONSHA KK (JP) 2003-05-14 EP disclosed
EP-1022277-B1 NEW TAXANE DERIVATIVES YAKULT HONSHA KK (JP) 2002-12-04 EP disclosed
US-6310210-B1 WATER-SOLUBLE AND EXCELLENT IN AN ANTI-TUMOR ACTIVITY KABUSHIKI KAISHA YAKULT HONSHA (JP) 2001-10-30 US disclosed
US-6268381-B1 Taxane derivatives KABUSHIKI KAISHA YAKULT HONSHA (JP) 2001-07-31 US disclosed
US-6136808-A ANTITUMOR AGENTS FROM PLANTS KABUSHIKI KAISHA YAKULT HONSHA (JP) 2000-10-24 US disclosed
EP-1029863-A1 NOVEL CAMPTOTHECIN DERIVATIVES Kabushiki Kaisha Yakult Honsha (JP) 2000-08-23 EP disclosed
EP-1022277-A1 NEW TAXANE DERIVATIVES Kabushiki Kaisha Yakult Honsha (JP) 2000-07-26 EP disclosed
US-6025385-A HIGH SOLUBILITY IN WATER AND ALSO HAS EXCELLENT ANTITUMOR ACTIVITIES. KABUSHIKI KAISHA YAKULT HONSHA (JP) 2000-02-15 US disclosed
EP-0930309-A1 TAXANE DERIVATIVES AND DRUGS CONTAINING THE SAME KABUSHIKI KAISHA YAKULT HONSHA (JP) 1999-07-21 EP disclosed